| Axon ID |
Name |
Description |
From price |
|
1129
|
BI 2536
|
PLK1 inhibitor |
€60.00 |
|
1131
|
GW 843682X
|
PLK1 and PLK3 inhibitor |
€85.00 |
|
1243
|
NSC 625987
|
CDK4 inhibitor |
€95.00 |
|
1473
|
BI 6727
|
PLK1 Inhibitor |
€90.00 |
|
1505
|
PD0332991 hydrochloride
|
CDK4 and CDK6 inhibitor |
€80.00 |
|
1539
|
AT 7519 mesylate
|
CDK inhibitor |
€80.00 |
|
1585
|
Nutlin-3
|
MDM2 inhibitor (p53 specific) |
€95.00 |
|
1597
|
Aurora A inhibitor I
|
Aurora A inhibitor |
€125.00 |
|
1614
|
SNS 032
|
CDK inhibitor (2, 7 and 9 specific) |
€85.00 |
|
1625
|
GSK579289A
|
PLK1 Inhibitor |
€110.00 |
|
1626
|
GSK 461364 analogue II
|
PLK1 Inhibitor |
€130.00 |
|
1630
|
Aurora A inhibitor II
|
Aurora A inhibitor |
€125.00 |
|
1643
|
HLI 373
|
HDM2 inhibitor |
€100.00 |
|
1688
|
GSK 461364
|
PLK1 inhibitor |
€105.00 |
|
1776
|
Dinaciclib
|
CDK inhibitor (1, 2, 5, and 9 specific) |
€90.00 |
|
1880
|
Nutlin-3a
|
Inhibitor of MDM2 |
€95.00 |
|
1881
|
Nutlin-3b
|
Less potent (+)-enantiomer of Nutlin-3 |
€90.00 |
|
1904
|
SMER 3
|
Inhibitor of an SCF family E3 Ubiquitin ligase |
€90.00 |
|
1910
|
MLN0905
|
PLK1 inhibitor |
€95.00 |
|
1953
|
PRT 4165
|
E3 Ubiquitin ligase Bmi1/Ring1A inhibitor |
€70.00 |
|
1961
|
MK 5108
|
Inhibitor of Aurora A kinase |
€110.00 |
|
1966
|
AZD5438
|
CDK inhibitor (1, 2, and 9 specific) |
€80.00 |
|
1983
|
R 547
|
CDK inhibitor (1, 2, and 4 specific) |
€95.00 |
|
2003
|
MLN8237
|
Second generation selective Aurora A inhibitor |
€90.00 |
|
2008
|
Tenovin 1
|
Activates p53 through inhibition of SIRT 1 and 2 |
€70.00 |
|
2009
|
RITA
|
Activates p53 through inhibition of MDM2 |
€105.00 |
|
2164
|
SJ 172550
|
Small molecule inhibitor of MDMX |
€95.00 |
|
2052
|
Palbociclib isethionate
|
Orally active cyclin-dependent kinase (CDK4/6) inhibitor |
€125.00 |
|
2249
|
Tenovin 6
|
Small water soluble p53 activator and SIRT inhibitor |
€105.00 |
|
2268
|
XL 413 hydrochloride
|
Potent, selective and orally bioavailable CDC7 inhibitor |
€120.00 |
|
2273
|
LEE 011
|
Orally bioavailable and highly selective small-molecule inhibitor of CDK4/6 |
€70.00 |
|
2437
|
SP 141
|
Specific MDM2 inhibitor with therapeutic effects in breast cancer models |
€120.00 |
|
1538
|
JNJ 26854165
|
HDM2 inhibitor |
€105.00 |
|
1586
|
JNJ 26854165 dihydrochloride
|
HDM2 inhibitor |
€105.00 |
|
2695
|
NSC 23005 sodium
|
Novel small molecule inhibitor of INK4C (p18(INK4C) or p18) |
€90.00 |
|
3184
|
SR-4835
|
Potent, highly selective and orally bioavailable dual CDK12/CDK13 inhibitor |
€130.00 |
|
3228
|
CDK inhibitor CR8
|
Potent CDK inhibitor (1, 2, 5, 7, and 9 specific) |
€130.00 |
|
3402
|
THZ531
|
First-in-class, potent, selective, covalent CDK12/CDK13 inhibitor |
€130.00 |
|
3525
|
ETP-47799
|
Potent CDK8/CDK19 inhibitor |
€90.00 |